The DOI matches its Crossref record.
Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment?
Open accessAbstract
Lung cancer is the second commonest cancer in the UK with an incidence in 2006 of 37 100, and is the commonest cause of death from cancer, causing more than 33 000 deaths (22% of cancer deaths) each year.1 More than three-quarters of lung cancers fall into the histological category of non-small cell lung cancer (NSCLC). Currently, 10% of patients with NSCLC present with symptomatic brain metastases, and between a quarter and a third of those who initially survive radical treatment for stage III NSCLC will go on to develop brain metastases during their remaining life span.2 It is anticipated that over the next decade, an increasing proportion will develop brain metastases as adjuvant chemotherapy, concurrent chemoradiotherapy for locally advanced disease and chemotherapy for metastatic disease result in longer overall survival times. For several decades, administration of steroids followed by whole brain radiotherapy (WBRT) has been standard treatment for inoperable multiple brain metastases of any primary cancer. The duration of survival for patients with a diagnosis of multiple brain metastases is strongly influenced by their performance status and also by the presence or absence of active extracranial disease. Data from three North American clinical trials which studied dose and fractionation for WBRT were used to divide patients with brain metastases from a variety of primary sites into three prognostic subgroups using recursive partitioning analysis (RPA).3 The group identified as having the best survival were aged less than 65 years, had a Karnofsky Performance Status score ⩾70 and had controlled primary disease with no metastases outside the brain. In this group, termed RPA class I, median survival was …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
MacDuff, A., Arnold, A., Harvey, J., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136986 · Cited by 1,481
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451
The Prevalence of Nonadherence in Difficult Asthma
Gamble, J., Stevenson, M., McClean, E., & Heaney, L. G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0166oc · Cited by 421
Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life
Kauppi, P., Kupiainen, H., Lindqvist, A., Tammilehto, L., Kilpeläinen, M., Kinnula, V. L., Haahtela, T., & Laitinen, T. (2011) · Journal of Asthma · doi:10.3109/02770903.2011.555576 · Cited by 283
Metadata
- Authors
- Barton, R.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2008-01-01
- Volume
- 63
- Issue
- 1
- Pages
- 1-2
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2112973571
- Cited by
- 194
- References
- 0
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment? https://app.cochat.ai/papers/10.1136/thx.2007.086215
- The paper
- Barton, R. (2008). Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment? Thorax. https://doi.org/10.1136/thx.2007.086215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.